These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34953597)
1. Sequential Liver, Kidney, and Autologous Stem Cell Transplant for AL Amyloidosis: A Case Report. Sevmis M; Aktas S; Alkara U; Kilercik H; Göksoy HS; Uyar M; Sevmis S Transplant Proc; 2022; 54(1):197-201. PubMed ID: 34953597 [TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report. Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation followed by autologous stem cell transplantation for acute liver failure caused by AL amyloidosis. Case report and review of the literature. Elnegouly M; Specht K; Zoller H; Matevossian E; Bassermann F; Umgelter A Ann Hepatol; 2016; 15(4):592-7. PubMed ID: 27236160 [TBL] [Abstract][Full Text] [Related]
7. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Tam M; Seldin DC; Forbes BM; Connors LH; Skinner M; Oran B; Quillen K; Sanchorawala V Amyloid; 2009; 16(2):103-7. PubMed ID: 20536404 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study. Xie W; Wang Q; Zhou F; Wang S; Sun Y; Cen X; Ren H; Qiu Z; Dong Y Int J Hematol; 2023 Aug; 118(2):231-241. PubMed ID: 37247070 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease. Abdallah AA; Alapat D; Kaur V; Atrash S J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821 [TBL] [Abstract][Full Text] [Related]
11. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. Gertz MA; Dispenzieri A JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805 [TBL] [Abstract][Full Text] [Related]
12. The Role of Autologous Stem Cell Transplantation in Amyloidosis. Vaxman I; Dispenzieri A Oncology (Williston Park); 2021 Aug; 35(8):471-478. PubMed ID: 34398591 [TBL] [Abstract][Full Text] [Related]
13. Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis. Rifkin SI; Weinstein SS Ren Fail; 2012; 34(5):664-6. PubMed ID: 22452410 [TBL] [Abstract][Full Text] [Related]
14. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement. Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388 [TBL] [Abstract][Full Text] [Related]
15. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients]. Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180 [TBL] [Abstract][Full Text] [Related]